North America High Throughput Screening Market Segmented By Product, By Technology, By Application, By End User and Country (United States, Canada, Mexico, Rest of North America)

ID: 6288
Pages: 244

Market Size, 2025

$11.41 Bn

Market Estimate, 2026

$12.50 Bn

Market Forecast, 2034

$26.03 Bn

CAGR, 2026–2034

9.60%

Executive Summary: North America High Throughput Screening Market

  • Market Scope: Comprehensive analysis of the North American high-throughput screening (HTS) sector, covering technology types, application areas, products, end-user settings, and country-level distributions.
  • Market Valuation: Valued at USD 11.41 billion in 2025, reaching USD 12.50 billion in 2026, and projected to expand to USD 26.03 billion by 2034, growing at a steady CAGR of 9.60% from 2026 to 2034.
  • Primary Growth Drivers: Advancements in assay kits and reagents, adoption of human stem cell-based screenings, rising demand for preclinical drug discovery systems, substantial government funding, and robust pharmaceutical R&D spending.

Key Market Segment Metrics

CategoryLeading Segment (Base Position)Fastest-Growing / High-Growth Segment
By TechnologyCell-based Assays (established standard for biological screening workflows)3D Cell Culture & Ultra-High-Throughput Screening (expanding rapidly via physiological relevance and speed)
By ApplicationPrimary Screening & Target Identification (core foundational phases of drug discovery pipelines)Toxicology (high-growth segment utilizing automated safety assays)
By ProductConsumables & Reagents (largest share driven by recurring daily testing and assay kits)Instruments & Software Services (growing via automation, robotics, and advanced data analytics platforms)
By End UserPharmaceutical & Biotechnology Companies (primary institutional buyers driving drug development)Contract Research Organizations / CROs (high-growth segment supported by outsourced R&D services)
By CountryUnited States (market leader propelled by massive pharma R&D budgets, combinatorial chemistry, and genomics)Canada (high-growth regional market supported by public infrastructure grants like CFI and specialized functional proteomics hubs)

Major Market Players & Industry Landscape

Market Structure: Highly competitive life sciences and drug discovery market dominated by multinational technology providers offering integrated automation, liquid handling, and assay solutions.

Key Companies: Agilent Technologies Inc., Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Tecan Group Ltd., Millipore, Bio-Rad Laboratories, Hamilton Company, Axxam S.p.A., and Aurora Biomed.

To learn more about this report, icon Download Free Sample Report

North America High Throughput Screening Market Size

The North America high-throughput screening market was valued at USD 11.41 billion in 2025. The market is projected to grow from USD 12.50 billion in 2026 to reach USD 26.03 billion by 2034, exhibiting a CAGR of 9.60% from 2026 to 2034.

Market Data Forecast forecasts the North America high-throughput screening market to expand to USD 26.03 billion by 2034.

MARKET DRIVERS

Advancements in Assay Kits and Stem Cell Research Demand

Factors such as advancements in a high number of assay kits and reagents used in top throughput screening techniques, the evolution of preclinical drug development and discovery systems, through the adoption of human stem cell-based high throughput screenings and assays are majorly driving the North American HTS market. Advancements of technologies leading to the emergence of innovative technologies and platforms like analytical tools that deal with massive amounts of data further expand the market. The rise in demand for high throughput screening devices in stem cell research for the assessment of excretion, metabolism, distribution, and absorption characteristics and investigation of functional activity further lavish the growth rate of the North America High Throughput Screening Market.

Government Funding and Expanding Applications in Drug Discovery

Also, availability of government funding, increasing demand and a growing number in applications of high throughput screening devices in the pharmacy industry, adoption of high throughput screening devices in production and research fields, rise in outsourced drug discovery services, collaborations of research and academic institutions with pharmaceutical industries for developing innovative ways for drug delivery are further catalyzing the growth of the North American high throughput screening market.

MARKET RESTRAINTS

High Equipment and Maintenance Costs in Research

Certain restraints are challenging the growth of North America's high throughput screening market. They are high costs, restrictions in budgets of academic institutions due to which they find difficulties in affording expensive instruments that are essential for research purposes. High Maintenance costs, other indirect expenses are likely to hinder the high throughput screening market during the forecast period.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2025 to 2034

Base Year

2025

Forecast Period

2026 to 2034

Segments Covered

By Technology, Application, Product, End User, and Region.

Various Analyses Covered

Global, Regional and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities

Countries Covered

United States, Canada, Mexico, Rest of North America

Market Leaders Profiled

Agilent Technologies Inc., Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Tecan Group Ltd., Millipore, Bio-Rad Laboratories, Hamilton Company, Axxam S.p.A., and Aurora Biomed.

 

REGIONAL ANALYSIS

Regionally, North America held the largest share globally, followed by Europe and the Asia Pacific. Growth in the developed regions, such as North America is primarily driven by the massive spending on pharmaceutical R&D and high adoption of HTS and availability of government funding, and major companies in this region.

The advances in combinatorial chemistry and genomics are responsible for the significant growth of the U.S. high throughput screening market. Also, huge investments by the biotechnology and pharmaceutical industry in terms of miniaturization, automation, and assay methodology for high throughput screening will further help in the growth of the North American market. The availability of government funding and the drug discovery techniques using 3D-cell cultures have increased popularity among companies competing to reach the market with a new drug molecule. According to the American Cancer Society, over 1.7 million cases are cancer occur each year, and about 606,880 Americans die in a single year. SPARC Drug discovery in Canada starts researching functional human proteomics and a high throughput screening facility to provide scientists access to equipment resources such as automation and liquid handling robotics, high content imaging, and high throughput functional screens it is funded by Canada Foundation for Innovation (CFI).

KEY MARKET PLAYERS

Companies playing a dominant role in the North America High Throughput Screening Market profiled in this report are Agilent Technologies Inc., Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Tecan Group Ltd., Millipore, Bio-Rad Laboratories, Hamilton Company, Axxam S.p.A., and Aurora Biomed.

MARKET SEGMENTATION

This research report on the North American HTS market has been segmented and sub-segmented into the following categories:

By Technology:

  • Cell-based Assays
    • 2D
    • 3D Cell Culture
  • Lab-on-a-chip
  • Ultra-High-Throughput Screening
  • Label-Free Technology
  • Bioinformatics

By Application:

  • Target Identification
  • Primary Screening
  • Toxicology
  • Others

By Product:

  • Consumables & Reagents
  • Instruments
  • Software & Services

By End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Government Research Institutes
  • Contract Research Organizations
  • Other End Users

By Country: 

  • The United States
  • Canada
  • Rest of North America

Trusted by 500+ companies. We respect your privacy and never share your data.

Please wait. . . . Your request is being processed

Related Reports

Click for Request Sample